/Investor DB

New Wave Ventures

Family office

London · Seed–Growth · 5 people tracked

Find your way into New Wave Ventures

Sign up to see every warm intro you have to New Wave Ventures

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the New Wave Ventures team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

New Wave Ventures treats investing as a people business, prioritising trustworthy, capable people over elaborate financial projections. It invests its own money without external investors, borrowings, leverage, or artificial exit deadlines, and is willing to co-invest with like-minded partners. Capital is provided through equity or loans, with the firm generally leaving competent leaders to run their businesses while contributing on strategic goals, operating plans and funding. Drawing on operational experience, the firm adds value by challenging assumptions, anticipating problems and helping overcome obstacles, seeking companies with the appetite and ability to scale globally. It uses the 'MIRACLES' acronym to describe the key characteristics it looks for in a business.

Source: firm website, verified Sep 27, 2026.

Stage
Seed–Growth
HQ
London, GB
Instruments
Equity · Debt
Founded
2010
Last 12 months
1 investment
Tracked investments
14

Team · 5 people

from the firm's website
Paul Newey

Co-founded New Wave Ventures in 2010 and serves as a director of several portfolio companies. Previously led Ocean Finance from its 1991 founding until its 2007 sale, stepping down as CEO in 2009.

Tim Bullock

Co-founder of New Wave Ventures (2010) and advisor to the firm, serving as chairman or director of several portfolio companies. Spent 26 years in banking and finance, including 14 years as a Managing Director at Lloyds Bank Group.

Clare Twemlow

A PwC-qualified chartered accountant who joined New Wave Ventures in 2012. She evaluates investment opportunities and sits on portfolio company boards, having previously held CFO and board roles at healthcare startups.

Ian Georgein

Joined New Wave Ventures in 2013 and serves as a director of several portfolio companies. Holds a PhD from the Roslin Institute, co-founded Enigma Diagnostics in 2004, and previously worked at Unilever Research and the Defence Science Technology Laboratory on spin-out formation.

Gareth Shilton· Consultantin

An advisor to New Wave Ventures with 24 years of experience in the mortgage and consumer credit markets. He was a director of Ocean Finance from 2007 and its CEO from 2009.

What they invest in

from 9 of 14 portfolio companies

Hardware ×6Medical Devices ×6Deep Tech ×4Healthtech ×4AI & Machine Learning ×3Digital Health ×2New Materials ×2Advanced Manufacturing ×1

HQs:United Kingdom×3

Investments · 14 tracked

founders shown can be your intro path
Charco Neurotechcharconeurotech.comin𝕏

Charco Neurotech develops the CUE1, a non-invasive device that uses vibratory stimulation to ease movement symptoms and improve quality of life for people with Parkinson's disease.

Digital HealthHardwareHealthtechMedical Devices

Co-investorsAmadeus Capital PartnersCambridge Angels groupUTECCrista Galli VenturesParkwalk Advisors

Echopoint Medicalechopointmedical.comin𝕏Nov 2025

Echopoint Medical develops cardiac technology focused on coronary physiology for interventional cardiology.

Deep TechHardwareHealthtechMedical DevicesLondon, GB

Antony Odell(CEO & co-Founder)inMalcolm Finlay(CMO & Co-founder)inAdrien Desjardins(CSO & Co-Founder)inPriscila Hancock(Executive Officer)Nijs van de Vaart(COO)inPri Hancock(CFO)in

Co-investorsUCL Technology FundQueen Mary University of LondonAlbionVCParkwalk Advisors

Endomagendomag.com

Endomag makes the Magseed marker, a magnetic seed used to localize breast cancer lesions before and during surgery as an alternative to guidewire localization.

BiotechHardwareHealthtechMedical Devices

Co-investorsClaret Capital PartnersMolten VenturesSussex Place VenturesDraper Esprit

Neuronosticsneuronostics.comin𝕏

Neuronostics develops BioEP, software that applies digital analysis of background EEG to generate biomarkers supporting epilepsy diagnosis for clinicians and neurology services.

AI & Machine LearningDigital HealthMedical Devices

John Terry(Founder)in

Co-investorsAscensionThe FSE GroupAscension VenturesBritish Business BankEmpirical VenturesInnovate UK

OssTecosstec.ukin

OSSTEC is a medical device startup developing a 3D-printed biomimetic knee implant intended for use in hospitals.

Deep TechHardwareHealthtechMedical DevicesLondon, GB

Alex Liddle(DPhil FRCS(Orth))in

Co-investorsEmbryo VenturesOxford Investment Opportunity Network (OION)Empirical Ventures

Panda Surgicalpanda-surgical.comin

Panda Surgical develops handheld robotic platforms with AI-powered software to enhance neurosurgeons' dexterity and control during minimally invasive brain and spine procedures.

AI & Machine LearningMedical DevicesRoboticsLondon, GB

Danail Stoyanov(Co-founder)Hani Marcus(Chief Medical Officer, Co-founder)inManios Dimitrakakis(Chief Executive Officer, Co-founder)inDan Stoyanov(Scientific Advisor, Co-founder)

Sparklsparkl.com

Sparkl provides infrastructure built around per-app "daemons" that expose application logic to both human users (via HTTPS browser apps) and AI clients (via MCP/OAuth) under a shared permission-grant system.

AI & Machine LearningData & InfrastructureDeveloper Tools

Surface Generationsurface-generation.comin𝕏

Surface Generation builds custom production equipment and its PtFS process-control platform for high-performance manufacturing applications such as in-situ consolidation, 3D printing, and automated tape lay-up.

Advanced ManufacturingDeep TechHardwareNew Materials

Ben Halfordin

Surrey NanoSystemssurreynanosystems.com

Surrey Nanosystems develops and manufactures Vantablack, an advanced nanomaterial coating that absorbs up to 99.965% of light, used to eliminate stray light and reflections.

Deep TechHardwareNew Materials

Co-investorsOctopus VenturesIP Group

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Barista VerdeDiscuvaMerrifield CentreNanna TherapeuticsPervasID

Portfolio news

latest coverage across their companies
Neuronostics raises £3M - The FSE Group

Neuronostics · thefsegroup.com · Jun 30, 2026

Principals & officers · per Companies House

what is this? ⓘ
Paul Anthony Newey

LLP designated member · since 2010

Clare Gillian Twemlow

LLP designated member · since 2012

Ian Michael Riorden George

LLP member · since 2013

Ownership & control

Paul Anthony Newey — 75–100% of voting rights, right to share surplus assets 75 to 100 percent limited liability partnership, right to appoint and remove members limited liability partnership

Frequently asked questions

How many investments has New Wave Ventures made?
New Wave Ventures has 14 tracked investments, including 1 dated in the last 24 months.
What stage does New Wave Ventures invest at?
New Wave Ventures invests at the Seed, Series A, Growth stages.
What sectors does New Wave Ventures focus on?
New Wave Ventures focuses on Healthtech, Medical Devices, Sector Agnostic.
Where is New Wave Ventures located?
New Wave Ventures is headquartered in London, GB.
Who does New Wave Ventures co-invest with?
New Wave Ventures most often shares deals with Amadeus Capital Partners, Ascension, Molten Ventures, among 11 tracked co-investors.

Similar investors

Featured in lists